CCRM Australia Executive Team
Silvio Tiziani
CEO, CCRM Australia
Silvio Tiziani is a pivotal figure in the establishment of CCRM Australia, having successfully secured funding from prestigious entities such as Monash University, MTP Connect, CSIRO, Cell Therapies Pty Ltd, and The Victorian Government. His role is integral to the organisation's success, particularly in leading the strategic alliance with the Centre of Commercialisation of Regenerative Medicine (CCRM) and serving as the Director of the Australian Regenerative Medicine Institute's external engagement, strategic planning and communications.
Silvio brings a wealth of knowledge and expertise to CCRM Australia, leveraging his extensive networks within industry, international organizations, and the state and federal government. His background encompasses a diverse range of private and public organisations, with a strong emphasis on laboratory-based institutions in the academic, health, and healthcare sectors.
In addition to his academic qualifications, including a Bachelor of Science from Swinburne University and a Master of Business Administration from Monash University, Silvio is also a graduate of the Australian Institute of Company Directors (GAICD). His skill set extends to financial analysis, budget management, business development, strategic planning, and corporate governance, complemented by his exceptional interpersonal skills that enable him to lead and inspire staff towards achieving organisational goals.
Dr Chih Wei Teng
Vice President Corporate Development, CCRM Australia
Chih Wei is the Vice President of Corporate Development at CCRM Australia, responsible for the development and operationalisation of CCRM Australia’s 5 Year strategy. In addition to his administrative role, Chih Wei actively works with biotechnology companies and academics to translate their innovation.
Chih Wei has completed a doctoral degree, researching how the translation of regenerative medicine can be improved with open collaborative innovation. His research showed that interdisciplinary collaboration result in new capabilities that not only improve translation outcomes but also support the development of competitive business models. Chih Wei has an MBA and a diploma thesis on business models of public versus private cord blood banking.
Prior to CCRM Australia, Chih Wei has worked for IBM for seven years where he handled portfolios of Energy and Utilities, Industrial Manufacturing as well as Healthcare and Life Sciences industries. In addition to his role at CCRM Australia, Chih Wei is also a Research Fellow at the Department of Management at Monash University where he works with industry on implementing Sustainable Procurement and research on the growth of SMEs.
Prof Alice Pébay AM
Chief Scientific Officer, CCRM Australia
Professor Alice Pébay AM is an accomplished medical researcher specialising in the fields of neuroscience and regenerative medicine. She holds a PhD in Neuroscience (Paris, 2001) and a BA in Psychology (Paris, 2010).
Alice’s research focusses on using patient stem cells to model degenerative diseases of the eye and brain. She has published over 120 academic manuscripts and is credited as an inventor of multiple patent applications. Alice has contributed to raising significant funds for research support, from competitive funding, philanthropy, and commercial entities. One of Alice's strengths lies in her extensive network of collaborators, both within Australia and internationally. She has successfully integrated her network into her strategic vision, fostering collaborations, and implementing progressive research directions.
Alice has held leadership positions within Stem Cells Australia and the Australasian Society for Stem Cell Research, both leading committees of stem cell research nationally and abroad.